Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers

被引:46
作者
Leclerc, Julie [1 ]
Tournel, Gilles [1 ]
Ngangue, Elisabeth Courcot-Ngoubo [1 ]
Pottier, Nicolas [1 ]
Lafitte, Jean-Jacques [2 ]
Jaillard, Sophie [3 ]
Mensier, Eric [3 ]
Lhermitte, Michel [1 ]
Broly, Franck [1 ]
Lo-Guidice, Jean-Marc [1 ]
机构
[1] Univ Lille Nord France, Equipe Accueil EA2679, Fac Med Pole Rech, F-59045 Lille, France
[2] CHRU, Serv Pneumol & Oncol Thorac, Hop Calmette, Lille, France
[3] Polyclin Bois, Dept Chirurg, Lille, France
关键词
Cytochrome P450; Gene expression; Lung; Non-small cell lung cancer; TaqMan low-density array; MESSENGER-RNA EXPRESSION; XENOBIOTIC-METABOLIZING ENZYMES; HUMAN PROSTACYCLIN SYNTHASE; TUMOR-SPECIFIC EXPRESSION; HUMAN LIVER-MICROSOMES; STEROL; 27-HYDROXYLASE; CYP2F1; GENE; VITAMIN-D; IMMUNOHISTOCHEMICAL LOCALIZATION; BRONCHOALVEOLAR MACROPHAGES;
D O I
10.1016/j.biochi.2009.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Susceptibility to lung diseases, such as lung cancer and chronic obstructive pulmonary disease, is largely influenced by the metabolic capacity of lung tissues. This capacity is partly determined by the expression profile of the cytochromes P450 (CYPs), a superfamily of enzymes that have relevant catalytic properties toward exogenous and endogenous compounds. Using quantitative real-time RT-PCR, we conducted a comprehensive analysis of the expression profile of the 57 human CYP genes in non-tumoral (bronchial mucosa and pulmonary parenchyma) and tumoral lung tissues of 18 patients with non-small cell lung cancer. This study highlights (i) inter-individual variations in lung expression for some CYPs, (ii) different CYP expression patterns between bronchial mucosa and pulmonary parenchyma, that indicate distinctive susceptibility of these tissues toward the deleterious effects of inhaled chemical toxicants and carcinogens, (iii) high intertumoral variability, that could have major implications on lung tumor response to anti-cancer drugs. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:292 / 306
页数:15
相关论文
共 128 条
[71]  
Mori M, 1996, CANCER, V77, P665, DOI 10.1002/(SICI)1097-0142(19960215)77:4<665::AID-CNCR12>3.3.CO
[72]  
2-L
[73]  
Murray GI, 1997, CANCER RES, V57, P3026
[74]   STYRENE METABOLISM BY CDNA-EXPRESSED HUMAN HEPATIC AND PULMONARY CYTOCHROMES P450 [J].
NAKAJIMA, T ;
ELOVAARA, E ;
GONZALEZ, FJ ;
GELBOIN, HV ;
RAUNIO, H ;
PELKONEN, O ;
VAINIO, H ;
AOYAMA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1994, 7 (06) :891-896
[75]   Prostacyclin in human non-small cell lung cancers [J].
Nana-Sinkam, P ;
Golpon, H ;
Keith, RL ;
Oyer, RJ ;
Sotto-Santiago, S ;
Moore, MD ;
Franklin, L ;
Nemenoff, RA ;
Geraci, MW .
CHEST, 2004, 125 (05) :141S-141S
[76]   The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis [J].
Nebert, Daniel W. ;
Dalton, Timothy P. .
NATURE REVIEWS CANCER, 2006, 6 (12) :947-960
[77]  
Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369
[78]  
NUSING R, 1990, EICOSANOIDS, V3, P175
[79]  
Oyama T, 2008, FRONT BIOSCI, V13, P5787
[80]   Cytochrome P450 expression (CYP) in non-small cell lung cancer [J].
Oyama, Tsunehiro ;
Sugio, Kenji ;
Uramoto, Hidetaka ;
Kawamoto, Toshihiro ;
Kagawa, Norio ;
Nadaf, Sorena ;
Carbone, David ;
Yasumoto, Kosei .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :2299-2308